3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Withdrawn
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Carcinoma, Non-Small-Cell Lung
6
Colorectal Neoplasms
5
Pancreatic Neoplasms
4
Breast Neoplasms
4
Recurrence
3
Squamous Cell Carcinoma of Head and Neck
2
Sarcoma
2
Ovarian Neoplasms
2
Neoplasms, Plasma Cell
2
Multiple Myeloma
2
Lymphoma
2
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Esophageal Neoplasms
2
Burkitt Lymphoma
2
Unspecified Adult Solid Tumor, Protocol Specific
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Spinal Cord Neoplasms
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Optic Nerve Glioma
1
Neuroblastoma
1
Neoplasms
1
Neoplasm Metastasis
1
Medulloblastoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Immunoblastic
1
Interventions
Dexamethasone
2
venetoclax
1
selinexor
1
ethanolamine oleate
1
daratumumab
1
Trimethoprim, Sulfamethoxazole Drug Combination
1
Trimethoprim
1
Sulfamethoxazole
1
Sodium Chloride
1
Saline Solution, Hypertonic
1
Saline Solution
1
Psychiatric Rehabilitation
1
Pentetic Acid
1
In Situ Hybridization, Fluorescence
1
In Situ Hybridization
1
Ethanol
1
Edetic Acid
1
Drug Therapy
1
Calcium Dobesilate
1
Biological Assay
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Immunoglobulin Light-chain Amyloidosis
×
Drug Therapy
×
Clear all
NCT01531751
2018-03-21
DIACAL
Fondazione IRCCS Policlinico San Matteo di Pavia
Phase 2
Withdrawn